Gregori Pietro, Perricone Giovanni, Franceschetti Edoardo, Giurazza Giancarlo, Papalia Giuseppe Francesco, Zà Pierangelo, Papalia Rocco
Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 00128 Roma, Italy.
Research Unit of Orthopaedic and Trauma Surgery, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 00128 Roma, Italy.
J Pers Med. 2023 Aug 25;13(9):1301. doi: 10.3390/jpm13091301.
(1) Background: Allograft prosthetic composite (APC) represents one of the techniques used for reconstruction in large proximal humeral bone deficits. The present systematic review aimed at summarizing the state of the art of the technique and analyzing its outcomes. (2) Methods: The PRISMA guidelines were followed to perform this systematic review. A systematic electronic search was performed using PubMed (MEDLINE), EMBASE, and the Cochrane Library databases. All the studies analyzing the rates of allograft prosthesis composite were pooled, and the data were extracted and analyzed. (3) Results: A total of 10 studies were eligible for inclusion in this systematic review for a total of 239 patients. The rate of patient satisfaction with surgery was reported in 7 studies with a mean of 86.4% ± 13.64. The mean constant score was 45.7 ± 3.51, the mean ASES score was 63.58 ± 8.37, and the mean SST was 4.6 ± 1.04. The mean revision rate observed was 10.32% ± 3.63 and the mean implant survival was 83.66% ± 14.98. (4) Conclusions: Based on the currently available data, allograft prosthesis composite represents a valuable option for the reconstruction of proximal humeral deficits. All studies analyzed showed the favorable impact of this surgical technique on clinical outcomes and patient satisfaction.
(1) 背景：同种异体移植假体复合物（APC）是用于大的肱骨近端骨缺损重建的技术之一。本系统评价旨在总结该技术的现状并分析其结果。(2) 方法：遵循PRISMA指南进行本系统评价。使用PubMed（MEDLINE）、EMBASE和Cochrane图书馆数据库进行系统的电子检索。汇总所有分析同种异体移植假体复合物发生率的研究，并提取和分析数据。(3) 结果：共有10项研究符合纳入本系统评价的标准，涉及239例患者。7项研究报告了患者对手术的满意度，平均为86.4%±13.64。平均Constant评分是45.7±3.51，平均ASES评分是63.58±8.37，平均SST是4.6±1.04。观察到的平均翻修率为10.32%±3.63，平均植入物生存率为83.66%±14.98。(4) 结论：基于目前可得的数据，同种异体移植假体复合物是肱骨近端缺损重建的一个有价值的选择。所有分析的研究均表明该手术技术对临床结果和患者满意度有积极影响。
